Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA

Castellsagué, XavierXavierCastellsaguéNaud, PauloPauloNaudSONG-NAN CHOWWheeler, Cosette MCosette MWheelerGermar, Maria Julieta VMaria Julieta VGermarLehtinen, MattiMattiLehtinenPaavonen, JormaJormaPaavonenJaisamrarn, UnnopUnnopJaisamrarnGarland, Suzanne MSuzanne MGarlandSalmerón, JorgeJorgeSalmerónApter, DanDanApterKitchener, HenryHenryKitchenerTeixeira, Julio CJulio CTeixeiraSkinner, S RachelS RachelSkinnerLimson, GenaraGenaraLimsonSzarewski, AnneAnneSzarewskiRomanowski, BarbaraBarbaraRomanowskiAoki, Fred YFred YAokiSchwarz, Tino FTino FSchwarzPoppe, Willy A JWilly A JPoppeBosch, F XavierF XavierBoschde Carvalho, Newton SNewton Sde CarvalhoPeters, KlausKlausPetersTjalma, Wiebren A AWiebren A ATjalmaSafaeian, MahboobehMahboobehSafaeianRaillard, AliceAliceRaillardDescamps, DominiqueDominiqueDescampsStruyf, FrankFrankStruyfDubin, GaryGaryDubinRosillon, DominiqueDominiqueRosillonBaril, LaurenceLaurenceBaril2023-02-172023-02-172014-08-150022-1899https://scholars.lib.ntu.edu.tw/handle/123456789/628269We examined risk of newly detected human papillomavirus (HPV) infection and cervical abnormalities in relation to HPV type 16/18 antibody levels at enrollment in PATRICIA (Papilloma Trial Against Cancer in Young Adults; NCT00122681).enHPV; cervical abnormality; infection; naturally acquired antibodies; risk reduction[SDGs]SDG3Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIAjournal article10.1093/infdis/jiu139246108762-s2.0-84905594748WOS:000340243500004https://api.elsevier.com/content/abstract/scopus_id/84905594748